Related Experiment Video
Updated: Dec 20, 2025

11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.3K
Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer
Yoo-Ah Kim1, Damian Wojtowicz1, Rebecca Sarto Basso1,2
1National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, 8600 Rockville Pike, Bethesda, 20894, USA.
Genome Medicine
|May 31, 2020
Summary
This study links cancer mutational signatures to pathway activity, revealing distinct causes for APOBEC and age-related mutations. Understanding these links aids in developing personalized cancer therapies.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Cancer genomes accumulate passenger mutations from various endogenous and exogenous sources.
- Mutational signatures characterize distinct mutagenic processes, crucial for understanding tumorigenesis.
Purpose of the Study:
- To investigate network-level associations between mutational signatures and cancer pathways.
- To identify functional pathways correlated with mutational signature strengths and those potentially causing specific signatures.
Main Methods:
- A network-based approach was employed, treating mutational signatures as cancer phenotypes.
- Integer linear programming was used to identify mutated pathways.
- Analysis was performed on a breast cancer dataset.
Main Results:
- Pathways associated with mutational signatures were identified at both expression and mutation levels.
- Distinct etiologies were found for APOBEC-related and clock-like mutational signatures.
- Clustered versus dispersed APOBEC mutations and two age-related signatures showed differential pathway correlations.
Conclusions:
- This study establishes a novel network-level association between mutational signatures and dysregulated pathways.
- Findings offer new insights into cancer mutagenic processes.
- Identified pathways and subnetworks can inform personalized drug therapy development.
Keywords:
APOBECBreast cancerClock-like signaturesContinuous cancer phenotypeGene networkMutational signatureNetwork-phenotype association
